1.Erbek SS, Erbek S, Yılmaz S, Topal O, Yucel E, Ozluoglu LN. Cochleovestibular dysfunction in ankylosing spondylitis. Audiol Neurotol 2006;11:294-300

2.Erbek SH, Erbek SS, Yılmaz I, Topal O, Ozgirgin N, Ozluoglu L, Alehan F. Vertigo in childhood: A clinical experience. Int J Pediatr Otorhinolaryngol 2006;70:1547-1554 

3.Erbek SS. Correlation of atopy and sinus opacification in patients with nasal polyposis. Otolaryngol Head Neck Surg 2006;135:994

4.Erbek S, Erbek SS, Tosun E, Cakmak O. A rare case of sarcoidosis involving the middle turbinates: an incidental diagnosis. Diagn Pathol 2006;1:44

5.Topal O, Erbek SS, and Erbek S. Schwannoma of the external auditory canal: a case report. Head Face Med. 2007;3:6

6.Erbek SS, Erbek S, Topal O, Cakmak O. The role of allergy in the severity of nasal polyposis. Am J Rhinol 2007;21:686-690 

7.Erbek SS, Yurtcu E, Erbek S, Atac FB, Sahin FI, Cakmak O. Proinflammatory Cytokine Single Nucleotide Polymorphisms in Nasal Polyposis. Arch Otolaryngol Head Neck Surg 2007;133:705-709

8.Erbek S, Erbek SS, Gokmen Z, Ozkiraz S, Tarcan A, Ozluoglu LN. Clinical application of vestibular evoked myogenic potentials in healthy newborns. Int J Pediatr Otorhinolaryngol 2007;71:1181-1185

9.Yilmaz S, Erbek S, Erbek SS, Ozgirgin N, Yucel E. Abnormal Electronystagmography in Rheumatoid Arthritis. Auris Nasus Larynx 2007;34:307-311

10.Topal O, Erbek SS, Erbek S, Ozluoglu LN. Subjective pulsatile tinnitus associated with extensive pneumatization of temporal bone. Eur Arch Otorhinolaryngol 2008; 265: 123-125

11.Erbek SS, Serefhanoglu K, Erbek S, Demirbilek M, Can F, Tarhan E, Turan H, Cakmak O. Clinical subgroups and antifungal susceptibilities in fungal culture-positive patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 2008; 265: 775-80

12.Erbek S, Erbek SS, Yilmaz S, Yucel E, Ozluoglu LN. Vestibular evoked myogenic potentials in Behcet’s disease. Eur Arch Otorhinolaryngol 2008; 265:1315-20

13.Borazan M, Karalezli A, Akova YA, Akman A, Kiyici H, Erbek SS. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Acta Ophthalmol. 2009; 87:549-54

14.Erbek S, Gokmen Z, Ozkiraz S, Erbek SS, Tarcan A, Ozluoglu LN. Vestibular evoked myogenic potentials in preterm infants. Audiol Neurootol. 2009;14:1-6

15.Topal O, Erbek SS, Kiyici H, Cakmak O. Expression of metalloproteinases MMP-2 and MMP-9 in antrochoanal polyps. Am J Rhinol. 2008;22:339-42

16.Erbek SS, Yurtcu E, Erbek S, Sahin FI. Matrix metalloproteinase-9 promoter gene polymorphism (-1562C>T) in nasal polyposis. Am J Rhinol Allergy. 2009; 23:568-70

17.Dogan R, Erbek S, Gonencer HH, Erbek HS, Isbilen C, Arslan G. Comparison of local anaesthesia with dexmedetomidine sedation and general anaesthesia during septoplasty. Eur J Anaesthesiol. 2010;27:960-964

18.Erbek SS, Erinanc H, Erbek S, Topal O, Kiyici H. Expression of a disintegrin and metalloproteinase 33 protein in nasal polyposis: an immunohistochemical study. Am J Rhinol Allergy. 2010;24:79-82

19.Topal O, Celik SB, Erbek S, Erbek SS. Risk of nasal septal perforation following septoplasty in patients with allergic rhinitis. Eur Arch Otorhinolaryngol. 2011; 268:231-3

20.Erbek SS. Fracture patterns of the nasal septum. Otolaryngol Head Neck Surg. 2011; 144:827

21.Ekinci S, Erbek SS, Yurtcu E, Sahin FI. Lack of association between eotaxin-1 gene polymorphisms and nasal polyposis. Otolaryngol Head Neck Surg. 2011; 145:1036-9.